- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Eltrombopag – July 2013
Eltrombopag tablets, 25 mg, 50 mg, 75 mg and 100 mg (as olamine), Revolade®
Last updated
8 November 2023